Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2025-12-25 @ 11:19 PM
Study NCT ID:
NCT04510493
Status:
COMPLETED
Last Update Posted:
2021-09-08
First Post:
2020-08-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-11
First Submit QC Date:
None
Study First Post Date:
2020-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-07
Last Update Post Date:
2021-09-08
Last Update Post Date Type:
ACTUAL